Related Experiment Video
Updated: Feb 12, 2026

Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Molecular genomic landscapes of hepatobiliary cancer
Tatsuhiro Shibata1,2, Yasuhito Arai2, Yasushi Totoki2
1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
Insights
This study reveals key genetic drivers for hepatocellular carcinoma (HCC) and biliary tract cancer, identifying molecular targets for improved diagnosis and treatment of these prevalent East Asian cancers.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Hepatocellular carcinoma (HCC) and biliary tract cancer are more prevalent in East Asia than in Western countries.
- Understanding the molecular drivers of these cancers is crucial for developing targeted therapies.
Purpose of the Study:
- To comprehensively analyze the genomic landscape of HCC and biliary tract cancer.
- To identify core driver genes and molecular alterations.
- To discover potential therapeutic targets and molecular classifications.
Main Methods:
- Analysis of 1340 multi-ethnic HCC genomes.
- Genomic profiling of biliary tract cancer genomes.
- Integrative multi-omics data analysis.
Main Results:
- Identified three core drivers (TP53, TERT, WNT signaling) for HCC.
- Identified five core drivers (TP53, ARID1A, KRAS, SMAD4, BAP1) and specific alterations for biliary tract cancer.
- Discovered complex mutational signatures and identified molecular classifications linked to clinical outcomes and therapeutic targets, including immune checkpoint molecules.
Conclusions:
- The genomic landscape of HCC and biliary tract cancer is complex and influenced by epidemiological factors.
- Molecular classifications correlate with clinical outcomes and suggest potential therapeutic strategies.
- Further research and international collaboration are essential for advancing precise treatments, diagnosis, and prevention.
Abstract:
Hepatocellular carcinoma (HCC) and biliary tract cancer are more frequent in East Asia including Japan than in Europe or North America. A compilation of 1340 multi-ethnic HCC genomes, the largest cohort ever reported, identified a comprehensive landscape of HCC driver genes, comprised of three core drivers (TP53, TERT, and WNT signaling) and combinations of infrequent alterations in various cancer pathways. In contrast, five core driver genes (TP53, ARID1A, KRAS, SMAD4, and BAP1) with characteristic molecular alterations including fusion transcripts involving fibroblast growth factor receptor 2 and the protein kinase A pathway, and IDH1/2 mutation constituted the biliary tract cancer genomes. Consistent with their heterogeneous epidemiological backgrounds, mutational signatures and combinations of non-core driver genes within these cancer genomes were found to be complex. Integrative analyses of multi-omics data identified molecular classifications of these tumors that are associated with clinical outcome and enrichments of potential therapeutic targets, including immune checkpoint molecules. Translating comprehensive molecular-genomic analysis together with further basic research and international collaborations are highly anticipated for developing precise and better treatments, diagnosis, and prevention of these tumor types.
Related Concept Videos
Genomics
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Molecular Models
Genome Size and the Evolution of New Genes
Molecular Orbital Theory II
Comparing Mitochondrial, Chloroplast, and Prokaryotic Genomes

